Airtel Defends Priority Postpaid Plan Before DoT Panel Says Prepaid Network Not Affected SP 500 Edges Higher as Healthcare Tech Lead Communication Services Lags SP 500 Hits New High as Healthcare and Tech Lead Utilities Slump US Productivity Growth Slows in Q4 as Unit Labor Costs Rise SpaceX IPO Filing Highlights Starlink as Key Profit Engine Ahead of Potential Nasdaq Listing Economic Impact of Trump Tariffs Under Scrutiny Insights from Tax Foundation Rigetti Computing Inc RGTI Q1 2026 Earnings NarrowerThanExpected Loss as Quantum Computing Firm Prepares for Commercial Scale Catalyst Pharmaceuticals CPRX Q1 2026 Earnings EPS Beat Signals Operational Strength Amid Quiet Revenue Reporting STRD Q1 2026 Earnings Preferred Stock Reports Significant Earnings Miss Amid Challenging Quarter SOHON Q2 2025 Earnings Preferred Dividend Coverage Reported Positive Amid Quiet Quarter GCMG Q1 2026 Earnings EPS Misses Estimates Amid Cautious Outlook CRCT Q1 2026 Earnings EPS Surges Past Estimates with 145 Beat MasTec MTZ Shows Modest Decline Amid Infrastructure Sector Pullback PAC Holds Steady Near 244 Grupo Aeroportuario Del Pacifico Shows Resilience Amid Sector Trends Compass Diversified Holdings CODI Slips 12 as Shares Approach Key Support at 1085 Marker Therapeutics MRKR Faces Pressure Stock Slips 21 to 14 Inspired Entertainment INSE Climbs 369 as Volume Picks Up Key Levels in Focus Navient Corporation JSM Q1 2026 Earnings EPS Surges Past Estimates Amid Mixed Operational Signals RMBI Q1 2026 Earnings Solid EPS Performance Amid Quiet Quarter ANRO Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Continues Investment in Pipeline Digi Power X Inc DGXX Q3 2025 Earnings Loss Per Share of 003 Reflects Continued Investment Phase Grace Therapeutics Inc GRCE Q1 2026 Earnings Narrowed Loss Beats Expectations Despite Stock Dip CCID Q1 2026 Earnings EPS Misses Estimates Shares Edge Higher Retail Investors Gain Direct Access to Anticipated SpaceX IPO Through Major Brokerage Platforms Penumbra Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher AIM ImmunoTech AIM Slips Amid Low Volume Support at 022 Holds Steady